Evaluasi Traffic Profile pada Jaringan Data Existing Universitas Riau

Quality Of Service is very significant to measures data network performance indicator in the existing system in Riau University. This paper discusses performance analysis of existing datanetworks Riau University. The detail of performance analysis consists of several parameters such as throughput, packet loss and delay. It uses approach Action Research. The measurement was conducted when idle condition. The result shows Economics Faculty in good performance and the opposite result is indicated by Fisheries Faculty. Traffic problems arising from accessing the peak season occurs due to scheduling KRS which does not refer to the numberof each user on the faculties

Perancangan Sistem Keamanan Jaringan TCP/IP Berbasis Virtual LAN dan Access Control List

Internet network that has been developed at this time is a network architecture based on TCP / IP.Each layer of the TCP / IP on the Internet provides an opportunity for a security hole. One of manyways of closing the security hole is to set the Access Control List (ACL) on the Internetwork layer.ACL is used to permit or deny the package from the host towards a specific purpose. ACL consistsof rules and conditions that determine and define the process network traffic at the router whetherthe package will be passed or not. Methods ACL is created on an existing VLAN network, thusincreasing the security of the network. Results of this research is with implement an ACL can blockinternet sites that can not be accessed by the user in a network. Then by applying ACL on VLAN,the access rights of a user on the network can be segmented, thus reducing the chance of spreading"a network virus" which can make a network busy

Superconducting NbN microstrip detectors

Superconducting NbN strip transmission line counters and coupling circuits were processed on silicon wafers using thin film techniques, and they were characterized with several methods to verify the design principles. The stripline circuits, designed using microwave design rules, were simulated using a circuit design tool enhanced to include modelling of the superconducting lines. The strips, etched out of the 282 nm thick top NbN film with resistivity 284 µ?cm at 20 K, have critical temperatures in the range 12 to 13 K and a critical current density approximately Jc(0) = 3.3·105 A/cm2. The linearized heat transfer coefficient between the strip and the substrate is approximately 1.1·105 W/(m2K) and the healing length is about 1.6 µm between 3 and 5 K temperatures. Traversing 5 MeV a-particles caused the strips to quench. No events due to electrons could be detected in agreement with the predicted signal amplitude which is below the noise threshold of our wideband circuitry. The strip bias current and hence the signal amplitude were limited due to a microbridge at the isolator step of the impedance transformer

Psychometric properties of the revised Developmental Behaviour Checklist scales in Dutch children with intellectual disability

The present study assessed the reliability and validity of the revised scales of the Developmental Behaviour Checklist (DBC) in a Dutch sample of children with intellectual disability (ID). The psychometric properties of the parent and teacher versions of the DBC were assessed in various subsamples derived from a sample of 1057 Dutch children (age range = 6-18 years) with ID or borderline intellectual functioning. Good test-retest reliability was shown both for the parent and teacher versions. Moderate inter-parent agreement and high one-year stability was found for the scale scores. Construct validity was satisfactory, although limited by high informant variance. The DBC scales showed good criterion-related validity, as indicated by significant mean differences between referred and non-referred children, and between children with and without a corresponding DSM-IV diagnosis. The reliability and validity of the revised DBC scales are satisfactory, and the checklist is recommended for clinical and research purposes

Socio-culture and Health Problem Factors on Traditional Medicine Use among Indonesian Adult: A Cross-sectional Analysis from National Survey

Traditional medicines utilization has been significantly increased over the past years. Knowledge on traditional medicine use and its influencing socio-culture and health problem factors especially among generationally-related group in Indonesia is still limited. This study aimed to determine the prevalence and the association socio-culture and health problems factors and traditional medicine use among adults which were middle-aged (millennial) and elder-adult (generation X) in Indonesia while controlling other covariates. of traditional medicine use among This cross-sectional study used the data from the Indonesia Family Life Survey wave 5 (2014): a cross-sectional national population survey. This national survey used a multistage stratified random sampling to select the respondents to response to a structured questionnaire interview. There were 10,325 adults passed our inclusion criteria for the analysis. The adult who was born between1960 to 1982 was called the Gen X, whereas the Millennia is for those who were born between 1983 and 2000. A multivariable logistic regression was used to identify the association. Among 10,325 respondents, 78.42 % were millennial while 21.58 % were generation x or older adults.  Less than a quarter of the respondents used traditional medicine (13.37 %; 95% CI: 12.73-14.04). The factor significantly associated with traditional medicine used among Indonesian adults were; be Gen X (adj. OR = 1.24, 95%CI= 1.08 -1.43), female (adj.OR1.27, 95%CI: 1.13 to 1.43, p<0.001) Islamic (adj. OR = 1.91, 95%CI= 1.47 -2.36), married (adj. OR = 1.64, 95%CI= 1.44 -1.87),lived in urban area (adj. OR = 1.48, 95%CI= 1.31-1.68). Other covariate were unhealthy (adj.OR: 1.36, 95% CI: 1.18-1.1.58), experienced headache (adj.OR: 1.50, 95% CI: 1.31-1.47),  experienced stomachache (adj.OR: 1.28, 95% CI: 1.12-.47), and experienced fever (adj.OR: 1.30, 95% CI: 1.15- 1.47). Sociocultural and age group as well as health problems were associated with traditional medicine use

Sequence of a complete chicken BG haplotype shows dynamic expansion and contraction of two gene lineages with particular expression patterns.

Many genes important in immunity are found as multigene families. The butyrophilin genes are members of the B7 family, playing diverse roles in co-regulation and perhaps in antigen presentation. In humans, a fixed number of butyrophilin genes are found in and around the major histocompatibility complex (MHC), and show striking association with particular autoimmune diseases. In chickens, BG genes encode homologues with somewhat different domain organisation. Only a few BG genes have been characterised, one involved in actin-myosin interaction in the intestinal brush border, and another implicated in resistance to viral diseases. We characterise all BG genes in B12 chickens, finding a multigene family organised as tandem repeats in the BG region outside the MHC, a single gene in the MHC (the BF-BL region), and another single gene on a different chromosome. There is a precise cell and tissue expression for each gene, but overall there are two kinds, those expressed by haemopoietic cells and those expressed in tissues (presumably non-haemopoietic cells), correlating with two different kinds of promoters and 5' untranslated regions (5'UTR). However, the multigene family in the BG region contains many hybrid genes, suggesting recombination and/or deletion as major evolutionary forces. We identify BG genes in the chicken whole genome shotgun sequence, as well as by comparison to other haplotypes by fibre fluorescence in situ hybridisation, confirming dynamic expansion and contraction within the BG region. Thus, the BG genes in chickens are undergoing much more rapid evolution compared to their homologues in mammals, for reasons yet to be understood.This is the final published version. It was originally published by PLOS in PLOS Genetics here: http://www.plosgenetics.org/article/info%3Adoi%2F10.1371%2Fjournal.pgen.1004417

Cost-effectiveness of apixaban and warfarin in the prevention of thromboembolic complications among atrial fibrillation patients

Background: To reduce the risk of thromboembolic complications, clinical guidelines recommend anticoagulation treatment for almost all atrial fibrillation (AF) patients. Although warfarin has long been the primary treatment alternative, now newer alternatives such as apixaban have proven effective in prevention of the thromboembolic complications of non-valvular AF. The aim of this study is to assess the cost-effectiveness of apixaban when compared with warfarin in the prevention of AF-associated thromboembolic complications in Finland.Methods: The assessment was performed with a lifetime Markov-model with the following health states: non-valvular AF, ischemic stroke, hemorrhagic stroke, other intracranial bleed, other major bleed, clinically relevant non-major bleed, myocardial infarction, and systemic embolism. The treatment efficacies were obtained from the ARISTOTLE trial. Representative Finnish input data were used for the model states, including background mortality, resource use, costs (in 2014 values), and EQ-5D-3L-based quality of life. The results (with 3 % annual discounting) are presented as incremental cost-effectiveness ratios [ICER, cost per quality-adjusted life year (QALY) gained], the expected value of perfect information (EVPI), and the probability of apixaban being cost-effective at various willingness-to-pay levels.Results: Apixaban increased life-expectancy by 0.17 years and quality-adjusted life-expectancy by 0.14 QALYs when compared with warfarin. Additional QALY was gained with apixaban at a cost of 1824 euros based on the deterministic analysis. The maximum EVPI was 649 euros/patient at 1282 euros per QALY gained in the probabilistic analysis. The probability of apixaban being cost-effective reached 80 % when the willingness-to-pay per QALY gained was 14,857 euros. In deterministic sensitivity analyses, ICERs varied from dominance of apixaban to additional QALY being gained at a cost of 12,312 euros.Conclusions: The ICERs obtained were well below the WHO-CHOICE threshold values for cost-effective interventions, suggesting that apixaban is a very cost-effective treatment alternative for warfarin in Finnish patients with AF